Elderly patients with hypertension drug choice

Easy elderly hypertensive patients showed isolated systolic hypertension, there are easily combined heart, brain, kidney and other diseases. Therefore, the choice of drugs should be especially careful. Elderly hypertensive patients the choice of anti-hypertensive drugs with the best role of slow, steady antihypertensive drugs, but without effect soon, short duration drugs. Pressure relief incremental, but not too aggressive. To the attention of both diseases. Even without kidney disease, compared with the young people, older persons, especially the elderly hypertensive renal function often have receded, not to use may be right kidney damage of drugs. Amlodipine (Norvasc) in the human body by the liver metabolism and kidney function right sound and beneficial, even in renal failure, also can be applied. Usually slow heart rate of elderly patients with hypertension, should not use beta-blockers and calcium channel blockers of the verapamil (verapamil) and diltiazem have angina pectoris Hypertension patients should use the same time to have hypertension and angina treatment, a drug choice of beta receptor blockers or calcium channel blockers. Exertional angina (that is quickly running and other activities of angina) or unstable angina patients. should be the first choice in beta receptor blockers, such as hypotension dissatisfied with the results, joint use of calcium channel blockers. Myocardial infarction in patients after infarction abnormal blood pressure is still elevated, and should be preferred to beta receptor antagonist, because beta receptor blockers can lower blood pressure, but also myocardial infarction after two prevention, reduction of myocardial infarction again or sudden cardiac death of important drug. If a single use of beta receptor antagonist not satisfied with the control of blood pressure, can be combined use of angiotensin converting enzyme inhibitors or calcium channel blockers. Heart failure is the first choice for patients with hypertension should not only lower blood pressure controlling heart failure drugs, such as angiotensin-converting enzyme inhibitor and diuretic antihypertensive drugs. For use or joint use of calcium channel blockers, Selection should not worsen heart failure amlodipine (Norvasc) or slow-release felodipine (Plendil), Selection will not add to the deterioration of heart failure nifedipine (nifedipine), diltiazem and verapamil (verapamil). A bronchial asthma, asthmatic bronchitis or pulmonary heart disease in patients with hypertension, should not be used or on anti-beta receptor antagonist, because beta receptor antagonist may bronchial spasm, exacerbation of asthma. These patients may choose to use calcium channel blockers, angiotensin converting enzyme inhibitors, antihypertensive drugs or diuretic Europium receptor antagonist. Diabetes with hypertension, should use the metabolism of glucose no adverse impact on the anti-hypertension drugs, Calcium channel blockers, angiotensin converting enzyme inhibitors or Europium receptor antagonist, instead of the preferred diuretic antihypertensive drugs and beta receptor antagonist. But with diabetes myocardial infarction patients should choose beta receptor antagonist. Blood hypertension patients should choose to lipid metabolism without adverse effects of antihypertensive drugs, such as angiotensin-converting enzyme inhibitors, calcium channel blockers and Europium-receptor antagonist, instead of the preferred diuretic drugs or antihypertensive beta-receptor blocker.